Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Results from the International, Multi-Center, Retrospective B-Holistic Study: Describing Treatment Pathways and Outcomes for Classical Hodgkin Lymphoma

Burhan Ferhanoglu, MD, Tae Min Kim, MD PhD, Amado Karduss, MD, David Brittain, MBBCh, FC Path, Cert Clin Haem, Gayane Tumyan, Mubarak Al Mansour, Marta Zerga, MD, Yuqin Song, MD PhD, Silvia Rivas-Vera, MD, Yok Lam Kwong, MD FRCP, Soon Thye Lim, MBBS, MRCP, Su-Peng Yeh, MD, Arif Abdillah, MD, Zhongwen Huang, Mehul Dalal, PhD, Hui Wan, MD PhD, Mark Hertzberg, MBBS PhDFRACP FRCPA

Blood (2020) 136 (Supplement 1): 32–34.

https://doi.org/10.1182/blood-2020-134885

Published: 2020

Journal Articles

A Mutation Pentad Defined Outcome of De Novo and Cytogenetically Normal Acute Myeloid Leukaemia in Young Adults

Blood (2019) 134 (Supplement_1): 1400.

https://doi.org/10.1182/blood-2019-130810

Published: 2019

Journal Articles

Daratumumab Monotherapy for Patients with Relapsed or Refractory (R/R) Natural Killer/T-Cell Lymphoma (NKTCL), Nasal Type: Updated Results from an Open-Label, Single-Arm, Multicenter Phase 2 Study

Blood (2019) 134 (Supplement_1): 1568.

https://doi.org/10.1182/blood-2019-123446

Published: 2019

Journal Articles

Oral Arsenic Trioxide, ATRA and Ascorbic Acid (AAA) Maintenance Following First Complete Remission in Acute Promyelocytic Leukemia - Long-Term Data and Unique Prognostic Indicators

Harinder Gill, FRCP, FRCPath, Rita Yim, PhD, Cyrus R Kumana, FRCP, Yok-Lam Kwong, MD

Blood (2019) 134 (Supplement_1): 3853.

https://doi.org/10.1182/blood-2019-125185

Published: 2019

Journal Articles

A Phase II Single-Arm Open-Labeled Study Evaluating Combination of Quizartinib and Omacetaxine Mepesuccinate (QUIZOM) in Newly Diagnosed or Relapsed/Refractory AML Carrying FlT3-ITD

Chunxiao Zhang, Garret MK Leung, MBBS, Sze Pui Tsui, MSc, Ho-Wan Ip, MBBS,FRCPA, Edmond S. K. Ma, MD, Chun Hang Au, PhD, Chris T.L. Chan, PhD, Ka Lam Nelson Ng, PhD, Sze Fai Yip, MD, Bonnie Kho, MD, Harold K K Lee, MD, Qing LIU, Thomas Wing Yan Leung, Yok Lam Kwong, MD FRCP, Anskar Yu Hung Leung, MD PhD

Blood (2019) 134 (Supplement_1): 3825.

https://doi.org/10.1182/blood-2019-126510

Published: 2019

Journal Articles

Oral Arsenic Trioxide in the Frontline Treatment of Newly-Diagnosed Acute Promyelocytic Leukemia: A 5-Year Prospective Cohort Study

Harinder Gill, MBBS, MRCP, FRCP, Cyrus R Kumana, FRCP, Yok-Lam Kwong, MD

Blood (2018) 132 (Supplement 1): 3990.

https://doi.org/10.1182/blood-2018-99-111801

Published: 2018

Journal Articles

Characterization of Genomic Landscape and Risk Stratification of De Novo Cytogenetically Normal Acute Myeloid Leukaemia

Blood (2018) 132 (Supplement 1): 5267.

https://doi.org/10.1182/blood-2018-99-118909

Published: 2018

Journal Articles

Daratumumab Monotherapy for Patients with Relapsed or Refractory (R/R) Natural Killer/T-Cell Lymphoma (NKTCL), Nasal Type: An Open-Label, Single-Arm, Multicenter Phase 2 Study

Won-Seog Kim, Hyeon-Seok Eom, Su-Peng Yeh, MD, Seok-Goo Cho, MD PhD, Dae Seog Heo, MD, Jin Seok Kim, MD PhD, Ming Yao, MD, Jun Zhu, Grace Gao, Lijia Zhang, Ming Qi, MD PhD, Huiqiang Huang, Yok Lam Kwong, MD FRCP

Blood (2018) 132 (Supplement 1): 1617.

https://doi.org/10.1182/blood-2018-99-111885

Published: 2018

Journal Articles

Interim Analysis Results from an International, Multi-Centre, Non-Interventional Retrospective Study to Describe Treatment Pathways, Outcomes, and Resource Use in Patients with Classical Hodgkin Lymphoma: B-CD30+ Hodgkin Lymphoma International Multi-Centre Retrospective Study of Treatment Practices and Outcomes (B-HOLISTIC)

Burhan Ferhanoglu, MD, Tae Min Kim, Gayane Tumyan, DMSc, MD PhD, Su-Peng Yeh, MD, David Brittain, MBBCh, FC Path, Cert Clin Haem, Amado Karduss, MD, Yok Lam Kwong, MD FRCP, Soon Thye Lim, MBBS, MRCP, FAMS, Mubarak Al Mansour, MD, Silvia Rivas-Vera, MD, Yuqin Song, MD PhD, Marta Zerga, MD, Julie Blair, PhD MD MPhil, Mehul Dalal, PhD, Hui Wan, MD PhD, Mark Hertzberg

Blood (2018) 132 (Supplement 1): 2917.

https://doi.org/10.1182/blood-2018-99-111146

Published: 2018

Journal Articles

Prospective Evaluation of Azacitidine Maintenance Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Harinder Gill, MD MBBS, MRCP, FRCP, FHKAM (MDcine), Albert Kwok Wai Lie, MD, Yok Lam Kwong, MD, Anskar Y.H. Leung, MD

Blood (2015) 126 (23): 5476.

https://doi.org/10.1182/blood.V126.23.5476.5476

Published: 2015

Journal Articles

Clinicopathologic Features and Outcome of Chinese Patients with Myelofibrosis

Harinder Gill, MBBS, MRCP (UK), FHKCP, FHKAM (MDcine), Yu Yan Hwang, MBBS, MRCP (UK), FHKCP, FHKAM (MDcine), Thomas Sau Yan Chan, MBBS, MRCP (UK), FHKCP, FHKAM (MDcine), Chi Chung Chan, MBBS, MRCP (UK), FHKCP, FHKAM (MDcine), Candia Hay Nun Chan, MBBS, MRCP (UK), FHKCP, FHKAM (MDcine), Herman S.Y. Liu, MD, Vivien Mak, MBBS, MRCP (UK), FHKCP, FHKAM (MDcine), Shek Ying Lin, MBBS, MRCP (UK), FHKCP, FHKAM (MDcine), Chi Kuen Lau, MD, Anskar Y.H. Leung, MD, Albert Kwok Wai Lie, MD, Yok Lam Kwong, MD

Blood (2014) 124 (21): 3174.

https://doi.org/10.1182/blood.V124.21.3174.3174

Published: 2014

Journal Articles

Bringing an Old Drug to a New Treatment Strategy in Treating FLT-ITD AML - Combination of Homoharringtonine and Sorafenib

Eric S.K. Ho, Stephen Sze Yuen Lam, Cheuk Him Man, PhD, Chae Yin Cher, Yok Lam Kwong, MD, Anskar Y.H. Leung, MD

Blood (2014) 124 (21): 3610.

https://doi.org/10.1182/blood.V124.21.3610.3610

Published: 2014

Journal Articles

STAT5b Gene Mutations and Their Association with a Unique Immunophenotype of CD4+CD56+TCRαβ Type LGL Leukemia

Takahiro Tanahashi, Kazuyuki Matsuda, PhD, Nodoka Sekiguchi, MD PhD, Sayaka Nishina, MD, Noriko Senoo, MD, Kaoko Sakai, Hitoshi Sakai, MD, Toshiro Ito, MD PhD, Takeki Mitsui, MD, PhD, Yok Lam Kwong, MD, Fumihiro Ishida, MD PhD

Blood (2014) 124 (21): 1652.

https://doi.org/10.1182/blood.V124.21.1652.1652

Published: 2014

Journal Articles

Oral Arsenic Trioxide - Based Maintenance Without Hematopoietic Stem Cell Transplantation At Second Remission In Acute Promyelocytic Leukemia - A Prospective Follow-Up Study Of 65 Patients

Harinder Gill, MBBS, MRCP (UK), Wing-Yan Au, MD, Yok Lam Kwong, MD

Blood (2013) 122 (21): 2678.

https://doi.org/10.1182/blood.V122.21.2678.2678

Published: 2013

Journal Articles

Oral Arsenic Trioxide Based Regimen As Salvage Treatment For Relapsed Or Refractory Mantle Cell Lymphoma

Harinder Gill, MBBS, MRCP (UK), Wing-Yan Au, MD, Winnie W.W. Cheung, MBBS, MRCP, FHKCP, FHKAM, Yok Lam Kwong, MD

Blood (2013) 122 (21): 4346.

https://doi.org/10.1182/blood.V122.21.4346.4346

Published: 2013

Journal Articles

A Novel Role Of Tescalcin-Sodium/Hydrogen Exchange Axis Underlying Sorafenib Resistance In FLT3-ITD + AML

Cheuk Him Man, Anskar Y.H. Leung, MD, Stephen Sze Yuen Lam, Murphy Ka Hei Sun, Howard Chun Hung Chow, Harinder Gill, MBBS, MRCP (UK), Yok Lam Kwong, MD

Blood (2013) 122 (21): 3848.

https://doi.org/10.1182/blood.V122.21.3848.3848

Published: 2013

Journal Articles

The Use of Clofarabine and Cytarabine Combination (CLARA) As Salvage Therapy for Relapsed and/or Refractory Acute Myeloid Leukemia (AML)

Anskar Y.H. Leung, MD, Eric Tse, MBBS, PhD, Herman S.Y. Liu, M.D., Joycelyn Sim, M.D., Bonnie C.S. Kho, M.D., Sze-Fai Yip, M.D., Harold K.K. Lee, M.D., Yok Lam Kwong, MD

Blood (2012) 120 (21): 1518.

https://doi.org/10.1182/blood.V120.21.1518.1518

Published: 2012

Journal Articles

Acquired Fms-Like Tyrosine Kinase 3 Internal Tandem Duplication (FLT3 ITD) During Leukaemic Transformation From Underlying Myelodysplasia: Successful Rescue with Sorafenib

Harinder Gill, MBBS, MRCP (UK), Cheuk Him Man, Karen Lam, Raymond Liang, MD, FRACP, MBBS, FRCP, Edmond Ma, MD, FRCP, FRCPath, Yok Lam Kwong, MD, Anskar Y. H. Leung, MD

Blood (2012) 120 (21): 4927.

https://doi.org/10.1182/blood.V120.21.4927.4927

Published: 2012

Journal Articles

Whole Genome Sequencing On Donor Cell Leukemia in a Patient with Multiple Myeloma Identified Gene Mutations That May Provide Insights to Leukemogenesis.

Eric S.K. Ho, MPhil, Howard C.H. Chow, MPhil, Chris T.L. Chan, PhD, Ruibang Luo, BE, Henry C.M. Leung, PhD, Siu Ming Yiu, PhD, Francis Y.L. Chin, PhD, Yok Lam Kwong, MD, Anskar Y.H. Leung, MD

Blood (2012) 120 (21): 2414.

https://doi.org/10.1182/blood.V120.21.2414.2414

Published: 2012

Journal Articles

A Population Based Study of 408 Cases of Acute Promyelocytic Leukemia Showing Changes in Epidemiology and Prognosis During Two Decades: Impact of Oral Arsenic Trioxide,

Wing-Yan Au, MD, Dennis Ip, MD, Oscar Mang, PhD, Kit Fai Wong, MD, Margaret Ng, MD, Thomas SK Wan, PhD, Eudora Chow, MD, Michael LG Wong, MD, Chi Kuen Lau, MD, Bhonnie Kho, MD, Ching Wa Lau, MD, Edmond SK Ma, MD, Cyrus Kumana, MD, Yok Lam Kwong, MD

Blood (2011) 118 (21): 3597.

https://doi.org/10.1182/blood.V118.21.3597.3597

Published: 2011

NARROW

Results from the International, Multi-Center, Retrospective B-Holistic Study: Describing Treatment Pathways and Outcomes for Classical Hodgkin Lymphoma

A Mutation Pentad Defined Outcome of De Novo and Cytogenetically Normal Acute Myeloid Leukaemia in Young Adults

Daratumumab Monotherapy for Patients with Relapsed or Refractory (R/R) Natural Killer/T-Cell Lymphoma (NKTCL), Nasal Type: Updated Results from an Open-Label, Single-Arm, Multicenter Phase 2 Study

Oral Arsenic Trioxide, ATRA and Ascorbic Acid (AAA) Maintenance Following First Complete Remission in Acute Promyelocytic Leukemia - Long-Term Data and Unique Prognostic Indicators

A Phase II Single-Arm Open-Labeled Study Evaluating Combination of Quizartinib and Omacetaxine Mepesuccinate (QUIZOM) in Newly Diagnosed or Relapsed/Refractory AML Carrying FlT3-ITD

Oral Arsenic Trioxide in the Frontline Treatment of Newly-Diagnosed Acute Promyelocytic Leukemia: A 5-Year Prospective Cohort Study

Characterization of Genomic Landscape and Risk Stratification of De Novo Cytogenetically Normal Acute Myeloid Leukaemia

Daratumumab Monotherapy for Patients with Relapsed or Refractory (R/R) Natural Killer/T-Cell Lymphoma (NKTCL), Nasal Type: An Open-Label, Single-Arm, Multicenter Phase 2 Study

Prospective Evaluation of Azacitidine Maintenance Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Clinicopathologic Features and Outcome of Chinese Patients with Myelofibrosis

Bringing an Old Drug to a New Treatment Strategy in Treating FLT-ITD AML - Combination of Homoharringtonine and Sorafenib

STAT5b Gene Mutations and Their Association with a Unique Immunophenotype of CD4+CD56+TCRαβ Type LGL Leukemia

Oral Arsenic Trioxide - Based Maintenance Without Hematopoietic Stem Cell Transplantation At Second Remission In Acute Promyelocytic Leukemia - A Prospective Follow-Up Study Of 65 Patients

Oral Arsenic Trioxide Based Regimen As Salvage Treatment For Relapsed Or Refractory Mantle Cell Lymphoma

A Novel Role Of Tescalcin-Sodium/Hydrogen Exchange Axis Underlying Sorafenib Resistance In FLT3-ITD + AML

The Use of Clofarabine and Cytarabine Combination (CLARA) As Salvage Therapy for Relapsed and/or Refractory Acute Myeloid Leukemia (AML)

Acquired Fms-Like Tyrosine Kinase 3 Internal Tandem Duplication (FLT3 ITD) During Leukaemic Transformation From Underlying Myelodysplasia: Successful Rescue with Sorafenib

Whole Genome Sequencing On Donor Cell Leukemia in a Patient with Multiple Myeloma Identified Gene Mutations That May Provide Insights to Leukemogenesis.

A Population Based Study of 408 Cases of Acute Promyelocytic Leukemia Showing Changes in Epidemiology and Prognosis During Two Decades: Impact of Oral Arsenic Trioxide,

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only